comparemela.com

Ainful Joint News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Optimized Hospital Care Improves Gout Treatment Uptake

Almost all people who received in-hospital treatment for a gout flare were using urate-lowering therapy within 6 months of discharge after a multifaceted intervention with nurse-led follow-up.

United kingdomCity ofMarkd russellNational health serviceAmerican college of rheumatologyBritish society for rheumatologyKing college londonEuropean alliance of associationsBritish societyCollege londonMedscape medical newsEuropean allianceAmerican collegeHyperuricemia hyperuricaemiaClinical guidelinesUk national health service

EMA Approves Factor VIII Deficiency Clotting Drug

European Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.

European medicines agencyEuropean commissionCommittee for medicinal products human useMedicinal productsHuman useSwedish orphan biovitrumHemophilia haemophiliaFactor viiiPain managementBlood vesselsBack painAinful jointJoint painEbrile responseGenomics genomic medicineFebrile child

FDA Approves Omalizumab for Multiple Food Allergy

Omalizumab reduced the incidence of allergic reactions to multiple food items in a double-blind trial.

United statesDivision of pulmonologyDrug administrationKelly stoneCritical careDrug evaluationFood allergyFood hypersensitivityNt specialtyEad and neck surgery ent specialityAllergy induced asthmaAllergic asthmaImmunoglobulin eEbrile responseImmunoglobulin aPain management

What Drives Fatigue in Psoriasis and PsA?

Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data.

United statesAlexander egebergDepartment of dermatology at bispebjerg hospitalJournal of the american academy dermatologyUniversity of copenhagenDanish skin cohortBispebjerg hospitalAmerican academyPsoriatic arthritisRthropathic psoriasisPsoriatic arthropathyProstate carcinomaAlignant prostate neoplasmProstate cancerAncer of the prostateProstate specific antigen

FDA Approves Drug to Reduce Accidental Food Allergies

The new indication makes Xolair (omalizumab) the first drug approved to mitigate allergic reactions to more than one food.

Drug administrationKelly stoneDrug evaluationFood allergyFood hypersensitivityNt specialtyEad and neck surgery ent specialityAllergy induced asthmaAllergic asthmaPain managementEbrile responseBiologic therapyAinful jointJoint painAdverse effectsSide effects

vimarsana © 2020. All Rights Reserved.